Intravesical is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: first-in-human trial
Background: Urinary symptoms are common for people with neurogenic lower urinary tract dysfunction (NLUTD). No nonprescription approach has been proven safe and effective for self-management of urinary symptoms. Our objective was to describe the safety and tolerability of Lactobacillus rhamnosus GG...
Main Authors: | Suzanne L. Groah, Amanda K. Rounds, Inger H. Ljungberg, Bruce M. Sprague, Jamie K. Frost, Rochelle E. Tractenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-10-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/1756287219875594 |
Similar Items
-
Preliminary validation of a Urinary Symptom Questionnaire for individuals with Neuropathic Bladder using Intermittent Catheterization (USQNB-IC): A patient-centered patient reported outcome.
by: Rochelle E Tractenberg, et al.
Published: (2018-01-01) -
Urinary Tract Infection in Children with Neurogenic Bladder Dysfunction
by: Yu.B. Bielan, et al.
Published: (2016-04-01) -
Pharmacological correction of neurogenic lower urinary tract dysfunction in children
by: T.P. Borysova, et al.
Published: (2020-04-01) -
Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction
by: E U Johnson, et al.
Published: (2013-01-01) -
In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
by: Banakhar M, et al.
Published: (2021-09-01)